ARTICLE SUMMARY:
In the second part of our interview, Mark Leahey addresses the changes taking place in the European regulatory regimen and how that is affecting US companies. He also talks about how the US political situation will impact medtech, and the ongoing public debate on balancing safety and innovation in the device industry.
This is the second part of our interview with Mark Leahey, who heads the Medical Device Manufacturers Association (MDMA), the Washington, DC-based trade association that focuses on representing small and mid-sized medtech companies.
